Peter Verhamme

Peter Verhamme

Auto-generated profile, based on publicly available information

Peter Verhamme

Catholic University of Leuven, Department of Cardiology, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2006 in Acta Clinica Belgica
Verified
Journal Article
Closed access
PVP. Verhamme
P. Verhamme
MHM. F. Hoylaerts
M. F. Hoylaerts
The endothelium plays a pivotal role in the regulation of the haemostatic balance. The function of endothelial cells exceeds far beyond providing a non-thrombogenic inner layer of the vascular wall which maintains the blood fluidity. In physiological circumstances endothelial cells carefully prevent thrombosis by different anticoagulant and antiplatelet mechanisms. Endothelial cells are involved in all major haemostatic pathways upon vascular injury and limit clot formation to the areas where haemostasis is needed to restore vascular integrity. Failure of this complex balance between pro- and anticoagulant systems because of genetic or acquired disturbances may result in bleeding or thrombosis. Endothelial heterogeneity assures adequate homeostasis in the different organs and parts of the vascular tree. The local environment induces heterogeneous endothelial cell phenotypes determined by local needs. This heterogeneity also explains the diverse pathological responses upon disturbed vascular integrity. Localised manifestation of thrombosis in spite of systemic procoagulant disturbances depends on vascular bed-specific properties. Endothelial dysfunction not only precedes atherogenesis but may also predispose to arterial thrombosis. The potential role of the endothelium in venous thrombosis with and without overt vessel wall injury is discussed. The vast majority of endothelial cells are located in the microvessels. Therefore, it is no surprise that endothelial cells play a key role in microcirculatory diseases such as thrombotic microangiopathies and diffuse intravascular coagulation. Microcirculatory endothelial cell activation is an important feature in all thrombotic microangiopathies. In diffuse intravascular coagulation, the endothelium is the interface between inflammation and inappropriate activation of the coagulation system.

16 October 2009 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
CDChristophe Dommke
Christophe Dommke
OTOliver Turschner
Oliver Turschner
JSJean-Marie Stassen
Jean-Marie Stassen
FWFrans Van de Werf
Frans Van de Werf
HLH. Roger Lijnen
H. Roger Lijnen
PVPeter Verhamme
Peter Verhamme

19 February 2009 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
PVPeter Verhamme
Peter Verhamme
MJMartine Jerome
Martine Jerome
GGGodelieve Goossens
Godelieve Goossens
JDJoanna Devis
Joanna Devis
GMGeert Maleux
Geert Maleux
MSMarguerite Stas
Marguerite Stas

28 February 2010 in Acta Cardiologica
Verified
Journal Article
Closed access
PVP. Verhamme
P. Verhamme
FKF. Kerkhof
F. Kerkhof
IBI. Buysschaert
I. Buysschaert
ERE. Rietzschel
E. Rietzschel
EGE. de Groot
E. de Groot
Carotid intima-media thickness (CIMT) can be measured non-invasively by means of B-mode ultrasound. Carotid ultrasonography is readily available and enables the assessment of the full spectrum of the atherosclerotic process, from normal artery walls to arterial occlusion. In population studies, CIMT correlates with present and future cardiovascular disease (CVD). The method has been well validated in histological and epidemiological studies. Controlled clinical trials have shown the value of CIMT as a surrogate marker to evaluate established therapies and novel anti-atherosclerotic drugs. At present, CIMT is increasingly being used as a surrogate aimed at reducing CVD risk at an individual level. In this paper we discuss the potential usefulness of CIMT as a risk marker in clinical programmes of CVD prevention


11 June 2007 in European Heart Journal
Verified
Journal Article
Open access
PDF file
PVPeter Verhamme
Peter Verhamme
WAWim Anné
Wim Anné
LHLieven Herbots
Lieven Herbots
MDMarion Delcroix
Marion Delcroix
PHPaul Herijgers
Paul Herijgers
A 52-year-old woman presented at the emergency department with deep vein thrombosis and pulmonary embolism (PE).